Table 3.
Mutation | Study regimen | Trial identifier |
---|---|---|
MLL-rearranged AML | ||
MLL-rearranged or NPM1mut | DSP-5336 (menin-MLL inhibitor) | NCT04988555 |
MLL-rearranged or NPM1mut | SNDX-5613 (menin-MLL inhibitor) | NCT04065399 |
None specified; relapsed or refractory AML | KO-539 (menin-MLL inhibitor) | NCT04067336 |
MLL-rearranged AML | EPZ-5676 (DOT1L inhibitor) | NCT01684150 |